SCHEMBL4687328

SCHEMBL4687328

C[C@@H](N)C(O)C(Cc1ccccc1)NC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CTRB1 P17538 3/20 0.48
CYP2D6 P10635 1/20 0.47
ALPI P09923 1/20 0.46
PKM P14618 1/20 0.46
PTGS1 P23219 1/20 0.46
XIAP P98170 1/20 0.46
SLC7A5 Q01650 1/20 0.46
SLC6A2 P23975 2/20 0.46
TAAR1 Q96RJ0 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
CYP2A6 P11509 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
BCHE P06276 1/20 0.46
LAP3 P28838 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3324393 0.85 LTA4H (0.49) NPC1RAB9ACTRB1LAP3ANPEP
SCHEMBL6193303 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL27798809 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL4687372 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL27418997 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL6192393 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL3627449 0.83 NPC1 (0.56) NPC1RAB9ACTRB1TAAR1SIGMAR1
SCHEMBL6340455 0.82 REN (0.58) NPC1RAB9A
SCHEMBL6942559 0.81 NPC1 (0.45) NPC1RAB9ACTRB1ALPIPKM
SCHEMBL6945454 0.81 NPC1 (0.45) NPC1RAB9ACTRB1ALPIPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740581-A4 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO INC (US) 2008-01-23 EP disclosed
EP-1817311-A2 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2007-08-15 EP disclosed
EP-1740581-A1 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER\"S DISEASE Merck and Co., Inc. (US) 2007-01-10 EP disclosed
WO-2006057945-A2 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2006-06-01 WO disclosed
WO-2005103043-A1 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE MERCK & CO., INC. (US) 2005-11-03 WO disclosed